Skip to main content

Table 1 Characteristics of the population stratified by tertiles of age

From: Computed tomography findings and prognosis in older COVID-19 patients

 

Population (:380)

Group 1

Aged 60–74 (:139)

Group 2

Aged 75–83 (:116)

Group3

Aged ≥ 84 (:125)

P-value

Age (years)

78(9)

68.(4)

79(2)

89(4)

-

Gender (M)

214(56)

99(71)

62(53)

53(42)

 < 0.001

Household situation

 Living at home

281(74)

115(83)

94(81)

72(58)

 < 0.001

Nutritional status

 Obese

60(16)

31(22)

18(16)

11(9)

0.01

 Underweight/malnourished

48(13)

5(4)

14(12)

19(15)

 < 0.001

PaO2/FIO2

271 (110)

265 (112)

282 (116)

267 (102)

0.12

Frailty

31(8)

9(6)

9(8)

13(10)

0.49

Pneumonia severity

 No oxygen therapy

128(34)

54(39)

38(33)

36(29)

0.22

 Oxygen by mask or nasal prongs

179(47)

49(36)

60(52)

70(57)

0.002

 NIV or HF oxygen

52(14)

22(16)

13(11)

17(14)

0.56

 Intubation and mechanical ventilation

17(5)

12(9)

5(4)

0(0)

0.003

Main comorbidities

 Diabetes mellitus

83(22)

27(19)

32(28)

24(19)

0.20

 Chronic heart failure

40(11)

9(6)

12(10)

19(15)

0.07

 Atrial fibrillation

50(13)

6(4)

19(16)

25(20)

 < 0.001

 Cognitive impairment

51(13)

4(3)

17(15)

30(24)

 < 0.001

 Hypertension

83(22)

33(24)

28(24)

22(18)

0.37

 Chronic kidney disease

50(13)

11(8)

18(16)

21(17)

0.07

 COPD

38(10)

7(5)

15(13)

16(13)

0.05

Hospital stay (days)

8 (IQR:19)

6.5 (IQR:17.2)

8.5 (IQR:19.8)

8 (IQR:21)

0.67

CT scan

 GGO

322(85)

128(92)

97(84)

97(78)

0.004

 Consolidation

156(41)

56(40)

52(45)

48(38)

0.57

 Pulmonary nodules

47(12)

9(6)

24(21)

14(11)

0.001

 Fibrosis

18(5)

5(4)

6(5)

7(6)

0.68

 Bronchiectasis

34(9)

12(9)

11(9)

11(9)

0.93

 Pleural effusion

86(23)

23(17)

21(18)

42(34)

0.001

 Emphysema

19(5)

4(3)

5(4)

10(8)

0.12

 Cardiomegaly

19(5)

2(1)

5(4)

12(10)

0.01

 Pericardial effusion

19(5)

3(2)

5(4)

11(9)

0.03

 Solid lesion

19(5)

3(2)

10(9)

6(5)

0.05

 Pulmonary embolism

10(3)

3(2)

4(3)

3(2)

0.75

 Subsegmental vascular enlargement

1(0)

0(0)

0(0)

1(0)

0.35

Outcome

 Clinical improvement

198 (52)

88 (63)

66 (57)

44 (35)

 < 0.001

 Death

95 (25)

19 (14)

24 (21)

52 (42)

 < 0.001

 No major change

14 (4)

6 (4)

4 (3)

4 (3)

0.88

 Transfer to a different hospital

71 (18)

24 (17)

22 (19)

25 (20)

0.85

  1. Data are reported as mean SD or median IQR and frequency %, as appropriated. Abbreviations: PaO2/FIO2 Partial pressure arterial oxygen/fraction of inspired oxygen ratio, NIV Non-invasive ventilation, HF High-flow, COPD Chronic obstructive pulmonary disease, GGO Ground glass opacity